214390.KS
Kyongbo Pharmaceutical Co., Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 5,420.00
−2.87%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 26.05x
- PEG TTM
- —
- Price / book
- 0.88x
- Price / sales
- 0.46x
- Price / cash flow
- 10.84x
Enterprise value
- Enterprise value
- KRW 273.7B
- EV / sales
- 0.98x
- EV / EBITDA
- 16.35x
- EV / EBIT
- 103.97x
- Market cap
- KRW 129.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026